Stacy Shifflett Shord

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. ncbi Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures
    Stacy S Shord
    University of Illinois at Chicago, College of Pharmacy M C 886, Chicago, Illinois 60612, USA
    Anticancer Res 25:4165-71. 2005
  2. ncbi Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Integr Cancer Ther 8:208-27. 2009
  3. ncbi Understanding and managing the possible adverse effects associated with bevacizumab
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    Am J Health Syst Pharm 66:999-1013. 2009
  4. ncbi The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease
    Stacy S Shord
    Department of Pharmacy Practice, University of Illinois, College of Pharmacy MC 886, 833 S Wood Street, Room 164, Chicago, IL 60612, USA
    Eur J Clin Pharmacol 65:651-8. 2009
  5. ncbi Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann Pharmacother 43:235-41. 2009
  6. ncbi Cytochrome P450 2C9 mediated metabolism in people with and without cancer
    S S Shord
    University of Illinois Medical Center, Clinical Research Center, Chicago, IL, USA
    Int J Clin Pharmacol Ther 46:365-74. 2008
  7. ncbi Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, 60612, USA
    J Am Pharm Assoc (2003) 48:487-93. 2008
  8. ncbi Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia
    Stacy S Shord
    University of Illinois College of Pharmacy, Chicago, Illinois 60612, USA
    J Oncol Pharm Pract 14:5-22. 2008
  9. ncbi Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
    Stacy S Shord
    Department of Pharmacy Practice, University of Illinois at Chicago, 60612, USA
    Biopharm Drug Dispos 27:191-6. 2006
  10. ncbi Evaluation of opioid induced nausea and vomiting in sickle cell disease
    Stacy Shifflett Shord
    Department of Pharmacy, University of Illinois, Chicago, IL 60612, USA
    Am J Hematol 83:196-9. 2008

Detail Information

Publications17

  1. ncbi Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures
    Stacy S Shord
    University of Illinois at Chicago, College of Pharmacy M C 886, Chicago, Illinois 60612, USA
    Anticancer Res 25:4165-71. 2005
    ..Materials and..
  2. ncbi Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Integr Cancer Ther 8:208-27. 2009
    ..These examples are included to demonstrate how to interpret the different studies and how to use these data to predict the likelihood of a clinically significant drug-botanical interaction...
  3. ncbi Understanding and managing the possible adverse effects associated with bevacizumab
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    Am J Health Syst Pharm 66:999-1013. 2009
    ..The adverse events associated with bevacizumab therapy are characterized, and the underlying pathophysiology, risk factors, frequency, and management of these events are described...
  4. ncbi The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease
    Stacy S Shord
    Department of Pharmacy Practice, University of Illinois, College of Pharmacy MC 886, 833 S Wood Street, Room 164, Chicago, IL 60612, USA
    Eur J Clin Pharmacol 65:651-8. 2009
    ..We conducted a prospective, open-label study in 54 adult subjects with sickle cell disease to determine the relationship between morphine concentrations, cytochrome P450 (CYP) 2D6 genotype, and clinical outcomes...
  5. ncbi Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann Pharmacother 43:235-41. 2009
    ..The Modified Diet in Renal Disease (MDRD) equation appears to be a more accurate estimate of GFR in patients with chronic kidney disease, but this equation has not been studied extensively in patients with cancer...
  6. ncbi Cytochrome P450 2C9 mediated metabolism in people with and without cancer
    S S Shord
    University of Illinois Medical Center, Clinical Research Center, Chicago, IL, USA
    Int J Clin Pharmacol Ther 46:365-74. 2008
    ..To compare cytochrome P450 activity in people with and without cancer and examine the relationship between CYP2C9 activity and serum cytokine levels...
  7. ncbi Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation
    Stacy S Shord
    College of Pharmacy, University of Illinois at Chicago, 60612, USA
    J Am Pharm Assoc (2003) 48:487-93. 2008
    ....
  8. ncbi Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia
    Stacy S Shord
    University of Illinois College of Pharmacy, Chicago, Illinois 60612, USA
    J Oncol Pharm Pract 14:5-22. 2008
    ....
  9. ncbi Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
    Stacy S Shord
    Department of Pharmacy Practice, University of Illinois at Chicago, 60612, USA
    Biopharm Drug Dispos 27:191-6. 2006
    ..v. bolus...
  10. ncbi Evaluation of opioid induced nausea and vomiting in sickle cell disease
    Stacy Shifflett Shord
    Department of Pharmacy, University of Illinois, Chicago, IL 60612, USA
    Am J Hematol 83:196-9. 2008
    ..In conclusion, many of our patients experienced nausea or vomiting with antiemetics infrequently prescribed on an as needed basis. This suggests a need for better approaches to manage nausea and vomiting in patients receiving opioids...
  11. ncbi Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines
    Stacy S Shord
    University of Illinois at Chicago, College of Pharmacy MC 886, Department of Pharmacy Practice, Chicago, Illinois 60612, USA
    J Exp Clin Cancer Res 28:76. 2009
    ..These metabolites appear to relate to sensitivity and tolerability of gemcitabine based on previous animal and laboratory studies...
  12. ncbi Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam
    Stacy S Shord
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois, Chicago, IL, USA
    Br J Clin Pharmacol 69:160-6. 2010
    ..The aim of the study was to determine the effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam in the plasma...
  13. ncbi Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab
    Jacqueline K Suen
    Department of Medicine, Section of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA
    Anticancer Drugs 18:827-9. 2007
    ..Treatment with cetuximab should be considered for human epidermal growth factor receptor expressing tumors in a palliative setting...
  14. ncbi Examining differences in weekly warfarin dose in patients with and without cancer
    Karen M Grogan
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Ther Drug Monit 29:638-43. 2007
    ....
  15. ncbi Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke
    Kathryn M Momary
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Ill, USA
    Cerebrovasc Dis 27:585-93. 2009
    ..We sought to determine whether cyclooxygenase-1 (PTGS1) genotype is associated with the ability of aspirin to inhibit platelet aggregation in patients at risk for stroke...
  16. ncbi Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature
    Karen I Sweiss
    University of Illinois at Chicago College of Pharmacy and University of Illinois Medical Center at Chicago, Chicago, Illinois, USA
    Drug Saf 31:989-96. 2008
    ..Encephalopathy occurs in 10-40% of patients treated with high-dose ifosfamide. Proposed risk factors for encephalopathy include hepatic or renal dysfunction, brain metastases, electrolyte imbalances and drug-drug interactions...
  17. ncbi Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer
    Stacy S Shord
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Illinois, USA
    Anticancer Drugs 17:207-15. 2006
    ..The results from this retrospective study provide data to support a larger prospective study to further investigate the associations between these concurrent medications and cisplatin-induced nephrotoxicity...